COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,705 Articles (22,913 medRxiv, 8,792 bioRxiv)

Most recent first Previous |  Page 116: Articles 1151-1160  | Next

Beyond Natural Antibodies: Scaffold-Based Generation of Novel Anti-3CLpro Nanobody Nb01
Zhan, Z., Luo, C., Xiong, J., Jiang, Y., Li, Y., Huang, F., Cai, Y., Liu, J.
10.1101/2025.05.06.652338 — Posted: 2025-05-07
Discovery of an Antiviral PROTAC Targeting the SARS-CoV-2 Main Protease Using an Allosteric Warhead
Veeck, C., Laube, L., Werner, A. D., Diederich, W., Becker, S.
10.1101/2025.05.03.652023 — Posted: 2025-05-07
Number of Austrian SARS-CoV-2 infections in the 2024/2025 season: Analysis of national wastewater data
Riedmann, U., Rauch, W., Schenk, H., Oberacher, H., Ioannidis, J., Pilz, S.
10.1101/2025.05.05.25327005 — Posted: 2025-05-06
Parametric Survival Analysis of Long COVID Among Hospitalized Patients in Zambia: A Retrospective Cohort Study on the Time to Symptoms Resolving
Malambo, W., Sampa-Kawana, M., Chanda, D., Folowshi, S., Hines, J. Z., Kaonga, P.
10.1101/2025.05.05.25327037 — Posted: 2025-05-06
Opioid prescribing to people on orthopaedic waiting lists during the COVID-19 pandemic in England: a study using OpenSAFELY-TPP
Higgins, R., Smith, R. M., Dillingham, I., Quinlan, J., Speed, V., Curtis, H. J., Wood, C., Wiedemann, M., Jani, M., Bacon, S. C., Mehrkar, A., Goldacre, B., The OpenSAFELY Collaborative, , MacKenna, B., Schaffer, A. L.
10.1101/2025.05.06.25326436 — Posted: 2025-05-06
A Cluster of Acidic Residues in the Cytoplasmic Domain of SARS-CoV-2 Spike is Required for Virion-Incorporation and Infectivity
Stoneham, C. A., Singh, R., De Leon, A., Tafelmeyer, P., Acosta, F., Fuori, A., Anderson, M., Ramirez, P. W., Schwartzer-Sperber, H. S., Pillai, S. K., Lewinski, M. K., Guatelli, J.
10.1101/2025.05.04.652125 — Posted: 2025-05-06
Ethnic inequalities in compulsory psychiatric hospital detentions during UK COVID-19 'lockdowns': A Regression Discontinuity Design in time study
Hildersley, R. R., Oswald, T., Bakolis, I., Becares, L., Dregan, A., Dyer, J., Hotopf, M., Ocloo, J., Stewart, R., Das-Munshi, J.
10.1101/2025.05.02.25326888 — Posted: 2025-05-06
Skeletal muscle properties in long COVID and ME/CFS differ from those induced by bed rest
Charlton, B. T., Slaghekke, A., Appelman, B., Eggelbusch, M., Huijts, J. Y., Noort, W., Hendrickse, P. W., Bloemers, F. W., Posthuma, J. J., van Amstel, P., Goulding, R. P., Degens, H., Jaspers, R. T., van Vugt, M., Wust, R.
10.1101/2025.05.02.25326885 — Posted: 2025-05-06
Risk factors for hospitalisation and death due to COVID-19 during endemic Omicron circulation, a population-based cohort study
Marking, U., Wahlstrom, E., Holm, J., Walther, S., Hanberger, H., Stralin, K.
10.1101/2025.05.05.25326987 — Posted: 2025-05-06
Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against 1 JN.1 Subvariants in Adult Participants
Figueroa, A. L., Girard, B., Edwards, D. K., Nasir, A., Johnson, K., Hack, S., Cao, X., de Windt, E., Urdaneta, V., Priddy, F., Das, R., Montefiori, D. C., Chalkias, S.
10.1101/2025.05.02.25325954 — Posted: 2025-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).